A detailed history of Two Sigma Securities, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Two Sigma Securities, LLC holds 22,825 shares of EW stock, worth $1.72 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
22,825
Previous 22,600 1.0%
Holding current value
$1.72 Million
Previous $2.09 Million 27.84%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $1.22 Million - $1.91 Million
20,419 Added 848.67%
22,825 $1.51 Million
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $202,825 - $226,909
2,406 New
2,406 $222,000
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $512,117 - $690,264
7,392 New
7,392 $512,000
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $73,695 - $94,347
-1,079 Reduced 27.96%
2,780 $207,000
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $317,865 - $414,032
3,859 New
3,859 $319,000
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $215,008 - $279,808
-3,200 Closed
0 $0
Q2 2020

Sep 10, 2020

SELL
$57.54 - $76.95 $316,470 - $423,225
-5,500 Reduced 63.22%
3,200 $221,000
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $425,853 - $569,506
7,401 Added 569.75%
8,700 $601,000
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $1.05 Million - $1.29 Million
-17,051 Reduced 92.92%
1,299 $286,000
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $443,747 - $563,471
9,710 Added 112.38%
18,350 $3.2 Million
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $4,839 - $5,848
114 Added 1.34%
8,640 $1.26 Million
Q1 2018

May 15, 2018

BUY
$37.19 - $47.45 $317,081 - $404,558
8,526 New
8,526 $1.19 Million
Q4 2017

Feb 14, 2018

SELL
$33.79 - $39.39 $183,445 - $213,848
-5,429 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $197,018 - $210,808
5,429
5,429 $593,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.